Cargando…
Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers
Progress in the management of rare diseases, including rare cancers, is dependent upon clinical trials; however, as many as 32% of rare-disease trials go uncompleted or unpublished due to insufficient accrual. Monitoring practices may differ between institutions. We sought to survey the regulatory s...
Autores principales: | Elliott, Zachary T., Goldberg, Zachary, Philips, Ramez, Johnson, Jennifer M., Kasner, Margaret T., Kelly, William K., Osipowicz, Sarah, Dampman, Rachael, Curry, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498538/ https://www.ncbi.nlm.nih.gov/pubmed/36136866 http://dx.doi.org/10.3390/clinpract12050072 |
Ejemplares similares
-
AACI is now an open access journal
por: Warrington, Richard
Publicado: (2009) -
Accrual monitoring in cardiovascular trials
por: Baldi, Ileana, et al.
Publicado: (2017) -
Biotechnological Potential of Araucaria angustifolia Pine Nuts Extract and the Cysteine Protease Inhibitor AaCI-2S
por: Sallai, Roberto Carlos, et al.
Publicado: (2020) -
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)
por: Freedman, Rachel A., et al.
Publicado: (2018) -
Low-Overhead Accrual Failure Detector
por: Ren, Xiao, et al.
Publicado: (2012)